Cyndeo Wealth Partners, LLC Intellia Therapeutics, Inc. Transaction History

Cyndeo Wealth Partners, LLC

  • $1.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024
SELL
$23.82 - $32.8 $285 - $393
-12 Reduced 0.15%
8,224 $226,000
Q4 2023

Jan 12, 2024
BUY
$23.16 - $32.34 $23,160 - $32,340
1,000 Added 13.82%
8,236 $251,000
Q3 2023

Oct 10, 2023
BUY
$31.62 - $45.78 $12,521 - $18,128
396 Added 5.79%
7,236 $228,000
Q2 2023

Jul 27, 2023
BUY
$34.58 - $46.03 $46,268 - $61,588
1,338 Added 24.32%
6,840 $278,000
Q1 2023

Apr 21, 2023
BUY
$33.3 - $44.82 $183,216 - $246,599
5,502 New
5,502 $205,000

Others Institutions Holding NTLA

# of Institutions
319
Shares Held
88.7M
Call Options Held
668K
Put Options Held
865K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.27B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Cyndeo Wealth Partners, LLC Portfolio

Follow Cyndeo Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cyndeo Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cyndeo Wealth Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email